Adjuvant Chemotherapy for BTC Based on 3D-PTA

Summary

This is a prospective, open-label, controlled, multicenter clinical study designed to observe and evaluate the efficacy and safety of chemotherapy (including capecitabine monotherapy) guided by 3D-PTA drug sensitivity testing versus capecitabine monotherapy as adjuvant treatment in patients with stage II/III cholangiocarcinoma after surgery.

Timeline

Start

2025-12

Primary completion

2027-10

Completion

2028-10

Drugs

Indications